Surgery Is Underutilized in the Management of Tertiary Hyperparathyroidism

J Surg Res. 2022 Sep:277:261-268. doi: 10.1016/j.jss.2022.04.003. Epub 2022 May 4.

Abstract

Introduction: Tertiary hyperparathyroidism (3HPT) is observed in up to 40% of renal transplant patients. Standard guidelines defining 3HPT and indications for operative intervention are not well described.

Methods: We conducted a retrospective, single-institution cohort study of patients who underwent renal transplant between January 1, 2012 and January 30, 2018, with a minimum of 13-month follow-up and at least 1 y of allograft function. We defined 3HPT as having elevated serum level parathyroid hormone (>88 pg/mL) after successful renal transplantation or multiple instances of elevated serum calcium starting at least 3 mo after transplant. We compared graft failure rates after stratifying the cohort based on management strategy: expectant, medical management with cinacalcet, and parathyroidectomy.

Results: Out of the 381 transplanted patients with functional grafts at 1 y, 178 patients (46.6%) were found to have 3HPT. One hundred twenty-nine patients (72.5%) were managed expectantly without medications, 35 patients (19.7%) were managed medically, and 14 patients (7.8%) were managed with parathyroidectomy. Twenty-two patients (17.1%) in the observation group had graft failure, 4 patients (11.4%) in the medically managed group had graft failure, and 0 patients in the surgery group had graft failure. Surgical intervention was associated with decreased renal allograft failure when compared to the combined cohort of nonoperative 3HPT patients (P = 0.03). All patients who underwent parathyroidectomy were cured and did not have graft failure as of December 30, 2019. Calcium elevation, but not PTH elevation, was associated with referral for parathyroidectomy on multivariable logistic regression analysis (P < 0.01).

Conclusions: At our institution, the referral rate for parathyroidectomy among patients with 3HPT remains low. Parathyroidectomy was associated with high cure rates and reduced graft failure. Surgery may be underutilized in the management of 3HPT.

Keywords: Cinacalcet; Parathyroidectomy; Renal transplant; Tertiary hyperparathyroidism.

MeSH terms

  • Calcium
  • Cohort Studies
  • Humans
  • Hyperparathyroidism* / etiology
  • Hyperparathyroidism* / surgery
  • Kidney Transplantation* / adverse effects
  • Parathyroid Hormone
  • Parathyroidectomy
  • Retrospective Studies

Substances

  • Parathyroid Hormone
  • Calcium